Physician profile

Daniel Friedman

Clinical Cardiac Electrophysiology · Bradenton, FL

NPI 1366633042

$226,331.63

in general payments reported to CMS, 2019-2025

30 companies · $50K in 2025

The $50K reported for 2025 was more than what 95% of Clinical Cardiac Electrophysiology providers received nationally (typical 2025 total: $2,477).

Payments by year

General payments by program year, as reported to CMS.

What the payments were for

Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.

View as a table
Payment typeAmount (2023-2025)
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program$91,312.50
Consulting Fee$34,059.56
Travel and Lodging$12,423.29
Food and Beverage$6,845.43

Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.

Who reported paying

General payments only, as reported to CMS. Product names cover 2023-2025.

CompanyGeneral paymentsYearsTop products
Boston Scientific Corporation $123,417.17 2019-2025 Watchman Access System, Watchman, Ingevity+
Abbott Laboratories $87,890.72 2019-2025 Tacticath Ablation Catheter, Sensor Enabled, Ensite, Ensite Precision
Terumo Medical Corporation $7,592.41 2019-2020
Elutia, INC. $4,542.86 2019-2025 Ecm Patch,Pouch
Biosense Webster, INC. $693.90 2021-2025 Carto 3, Nuvision Ice Catheter, Qdot Micro Catheter
Siemens Medical Solutions USA, INC. $508.38 2023-2025 Acuson Origin Diagnostic Ultrasound System
Medtronic, INC. $404.04 2023-2025 Aurora Ev-Icd Mri Surescan, Micra, Azure Xt Dr Mri Surescan
Cardiva Medical, INC. $338.74 2021-2024 Esophageal Cooling Device, Cardiva Vascade 6/7f Vcs
Inari Medical, INC. $160.95 2023-2024 Flowtriever Catheter, S, Ct Thrombectomy System Kit
Philips North America LLC $89.73 2024-2025 (Ck4) Mcot, Ecc Solutions, (Ck7) Extended Holter
Novartis Pharmaceuticals Corporation $78.74 2021-2025
E.R. Squibb & Sons, L.L.C. $70.21 2024-2025 Eliquis, Camzyos
Zoll Services LLC (A/K/A Zoll Lifecor Corp) $65.34 2024-2025 Lifevest
Innovation Technologies INC $60.12 2021-2025 Irrisept
Stryker Corporation $48.74 2025 Flowtriever, Ct Thrombectomy System Kit, Flowtriever Catheter, S
Show all 30 companies
CompanyGeneral paymentsYearsTop products
Cardinal Health 200 LLC $44.22 2019
Alnylam Pharmaceuticals INC. $40.64 2019-2025 Onpattro
Amgen INC. $39.29 2024-2025 Repatha, Repatha
Janssen Pharmaceuticals, INC $35.53 2021
Medtronic Vascular, INC. $28.92 2019
Merck Sharp & Dohme LLC $24.81 2022
Novo Nordisk INC $22.36 2025 Wegovy
Altathera Pharmaceuticals LLC $21.99 2025 Sotalol Hydrochloride
Astrazeneca Pharmaceuticals Lp $20.95 2024 Wainua
Sanofi-Aventis U.S. LLC $17.90 2021
Pfizer INC. $17.57 2024
Kowa Pharmaceuticals America, INC. $17.33 2022
Bayer Healthcare Pharmaceuticals INC. $17.00 2021
Cardiovascular Systems INC. $11.07 2022
Bardy Diagnostics, INC. $10.00 2020

Drugs and devices associated with these payments

CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.

If you want to bring it up

Most clinicians are glad to talk about this. A respectful way in:

These are normal questions. A good clinician will welcome them.

Share this page

Payment summary

Daniel Friedman

$226,331.63

in general payments reported 2019-2025

Years
2019-2025
Top company
Boston Scientific Corporation
Context
The $50K reported for 2025 was more than what 95% of Clinical Cardiac Electrophysiology providers received nationally (typical 2025 total: $2,477).

https://glasscript.com/doctor/243263/daniel-friedman

Source: CMS Open Payments, program years 2019-2025. Payments are legal and often routine.

Keep an eye on this page

Get an email when the next June refresh changes this page. No account needed.

Watch this doctor

Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.